These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10908012)

  • 1. A comparison of injecting and noninjecting methamphetamine users.
    Domier CP; Simon SL; Rawson RA; Huber A; Ling W
    J Psychoactive Drugs; 2000; 32(2):229-32. PubMed ID: 10908012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran.
    Mehrjerdi ZA; Abarashi Z; Noroozi A; Arshad L; Zarghami M
    Int J STD AIDS; 2014 May; 25(6):420-7. PubMed ID: 24287028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methamphetamine use and HIV risk among substance-abusing offenders in California.
    Farabee D; Prendergast M; Cartier J
    J Psychoactive Drugs; 2002; 34(3):295-300. PubMed ID: 12422940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A descriptive analysis of participant characteristics and patterns of substance use in the CSAT methamphetamine treatment project: the first six months.
    Reiber C; Galloway G; Cohen J; Hsu JC; Lord RH
    J Psychoactive Drugs; 2000; 32(2):183-91. PubMed ID: 10908006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine use, self-reported violent crime, and recidivism among offenders in California who abuse substances.
    Cartier J; Farabee D; Prendergast ML
    J Interpers Violence; 2006 Apr; 21(4):435-45. PubMed ID: 16501213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The matrix model of outpatient stimulant abuse treatment: history and description.
    Obert JL; McCann MJ; Marinelli-Casey P; Weiner A; Minsky S; Brethen P; Rawson R
    J Psychoactive Drugs; 2000; 32(2):157-64. PubMed ID: 10908003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History of the methamphetamine problem.
    Anglin MD; Burke C; Perrochet B; Stamper E; Dawud-Noursi S
    J Psychoactive Drugs; 2000; 32(2):137-41. PubMed ID: 10908000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009.
    Wilkins C; Sweetsur P; Griffiths R
    Drug Alcohol Rev; 2011 May; 30(3):255-63. PubMed ID: 21545555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection methamphetamine use is associated with an increased risk of attempted suicide: a prospective cohort study.
    Marshall BD; Galea S; Wood E; Kerr T
    Drug Alcohol Depend; 2011 Dec; 119(1-2):134-7. PubMed ID: 21676557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver.
    Fairbairn N; Wood E; Stoltz JA; Li K; Montaner J; Kerr T
    Public Health; 2008 Jan; 122(1):70-8. PubMed ID: 17645904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment.
    Gonzales R; Marinelli-Casey P; Shoptaw S; Ang A; Rawson RA
    J Subst Abuse Treat; 2006 Sep; 31(2):195-202. PubMed ID: 16919748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting.
    Cunningham JK; Liu LM; Muramoto M
    Addiction; 2008 Jul; 103(7):1174-86. PubMed ID: 18422822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of outpatient drug treatment drop-out among methamphetamine users.
    Maglione M; Chao B; Anglin MD
    J Psychoactive Drugs; 2000; 32(2):221-8. PubMed ID: 10908011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment response by primary drug of abuse: does methamphetamine make a difference?
    Luchansky B; Krupski A; Stark K
    J Subst Abuse Treat; 2007 Jan; 32(1):89-96. PubMed ID: 17175402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CSAT methamphetamine treatment program: research design accommodations for "real world" application.
    Huber A; Lord RH; Gulati V; Marinelli-Casey P; Rawson R; Ling W
    J Psychoactive Drugs; 2000; 32(2):149-56. PubMed ID: 10908002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.
    Martin M; Vanichseni S; Suntharasamai P; Mock PA; van Griensven F; Pitisuttithum P; Tappero JW; Chiamwongpaet S; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
    Int J Drug Policy; 2010 Jul; 21(4):296-301. PubMed ID: 20079620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.